Searched for
SOFOSBUVIR
Mylan set to use hepatitis C combo drugs in COVID-19 phase-2 trialsThe SEC on Covid-19 permitted the company to conduct phase-II trials with caveats such as that the participants should not be more than 65 ...- Natco Pharma launches Hepatitis C drug in IndiaNatco Pharma launched fixed dose combination of Sofosbuvir-Daclatasvir tablets for the treatment of Hepatitis C under the brand name Hepcin...
- Hetero gets DCGI nod for generic chronic hepatitis C drugThe company "has received the approval for the generic version of 'Sofosbuvir+Velpatasvir' combination from the Drugs Controller General of...
- Government's patent grant to Gilead challenged in Delhi High CourtGilead has claimed existing public knowledge as its own and its patent on sofosbuvir, the base compound in its HepC drug Sovaldi, is "unmer...
- Blockbuster Hepatitis C drug now under price controlDrug-pricing watchdog National Pharmaceutical Pricing Authority (NPPA) has brought under price control revolutionary drug 'Sofosbuvir' pres...
- Mylan launches generic Hepatitis C drug in IndiaDrug firm Mylan NV has launched generic Harvoni tablets, used to treat Hepatitis C, under the brand name 'MyHep LVIR' in India.
- Biocon introduces advanced therapy to treat Hepatitis CBiotechnology major Biocon launches advanced novel therapy for the treatment of Hepatitis C at a fraction of the global cost.
- Natco gets DCGI nod to launch hepatitis C drug in IndiaNatco Pharma has received approval from the Drugs Controller General of India (DCGI) to launch generic version of hepatitis C treatment dru...
- Hetero receives drug controller approval for generic DaclatasvirDaclatasvir in combination with Sofosbuvir is indicated for the treatment of Hepatitis C genotype 3 infections, which is highly prevalent i...
- Hetero gets DCGI approval to market Hepatitis C drugHetero is the first company in India to receive the approval for the fixed-dose combination Ledipasvir-Sofosbuvir (90mg/400mg) from DCGI.
- Hepatitis C cure may cost as low as Rs 67,000India is now one of the few countries where generics are available for interferon-free treatment of Hepatitis C.
- Mylan Pharmaceuticals launches generic hepatitis C drug MyHep in IndiaUS-based company's Indian arm Mylan NV has launched generic Sofosbuvir tablets in strength of 400 mg under the name MyHep in the country, i...
- Strides Arcolab launches generic version of SofosbuvirStrides Arcolab today announced launch of the generic version of Hepatitis C drug 'Sofosbuvir' under the brand name 'Virso'.
- Dr Reddy's to launch Hepatitis C drug in IndiaSofosbuvir is a medicine used for chronic Hepatitis C infection and sold globally by Gilead Sciences Inc, under its brand Sovaldi.
- Zydus Cadila launches Gilead's Hepatitis C drug in IndiaSofosbuvir is a medicine used for chronic hepatitis C infection and sold globally by Gilead Sciences Inc, under its brand Sovaldi.
- Natco Pharma shares soar 15 per centAfter surging 19 per cent to its 52-week high at Rs 2,132.60 in intra-day trade, shares of Natco closed at Rs 2,056.85, up by 14.78 per cen...
- Natco Pharma gets nod to sell Hepatitis C medicine in IndiaThe company has received approval for generic sofosbuvir tablets in the strength of 400 mg from Drugs Controller General (India).
- Natco Pharma ties up with Gilead on hepatitis C drugsNatco will fix its own price for the generic versions, and will pay a royalty on sales to Gilead, the company said.
- New drug combo cures toughest cases of hepatitis CResults were similar in study participants infected with genotypes 2 or 3, strains which are less common in the US.
- US group seeks to block Gilead drug patent in India"India's patent law doesn't give monopolies for old science or for compounds already in the public domain," Tahir Amin, director of I-MAK s...
Load More
